• CONTACT US: +92 51 8738362-5
  • EMAIL: [email protected]
  • ABOUT US
    • CORPORATE HISTORY –
    • BUSINESS PARTNERSHIPS –
    • QUALITY CONTROL & QUALITY ASSURANCE –
    • MANUFACTURING EXPERTISE –
    • MARKETING & SALES –
  • OUR DIVISIONS
    • PHARMA HEALTH DIVISION –
    • ANIMAL HEALTH DIVISION –
    • BIO-LABS CONSUMER HEALTH
  • PRODUCTS
    • ALL FEATURED BRANDS
    • PHARMA HEALTH PRODUCTS LIST
    • ANIMAL HEALTH PRODUCTS LIST
  • GLOBAL PRESENCE –
  • BIO-LABS SUBSIDIARIES –
    • Bio-Next Pharmaceuticals –
    • Bio-Labs Consumer Health –
    • ZH Therapeutics –
  • CSR –
  • NEWS & PRESS –
  • CAREERS –
  • CONTACT
0
  • Home
  • News
  • MOLNUCAP Capsules (Molnupiravir) breakthrough new drug for COVID-19
Bio-Labs received the “Leading Pandemic Healthcare & Pharmaceutical Company Award”
November 23, 2021
Bio-Labs Has Successfully Launched another Prime Life-Saving Drug: Merobio (Meropenem)
January 8, 2022
December 15, 2021

Bio-Labs is proud to be the first pharmaceutical company in Pakistan to launch the breakthrough new drug for COVID, Molnupiravir capsules, under the brand name of MOLNUCAP for export markets. After RIVONA injection (Remdesivir) and FAVILAB tablets (Favipiravir) successful launches, this is another feather in the cap of Bio-Labs for bringing the newest medicines to combat the COVID pandemic for patients globally.

 

Share

Related posts

June 14, 2022

Bio-Labs Signed MOU with N-ovative Health Technologies (NHT), for cardiac stents & catheters


Read more
June 7, 2022

Bio-Labs – Donated medicines to Sri Lanka


Read more
February 14, 2022

Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division


Read more

 

Bio-Labs is an innovative healthcare company expert in manufacturing and quality control of high-end pharmaceutical products.

  • Contact US: +92 51 8738362-5
  • EMAIL: [email protected]
  • ADDRESS: ISLAMABAD, PAKISTAN

QUICK LINKS

  • HOME
  • CORPORATE HISTORY
  • PHARMA HEALTH DIVISION
  • ANIMAL HEALTH DIVISION
  • PRODUCTS
  • NEWS & PRESS
  • CAREERS
  • CONTACT

RECENT POST

  • 0
    Bio-Labs Signed MOU with N-ovative Health Technologies (NHT), for cardiac stents & catheters
    June 14, 2022
  • 0
    Bio-Labs – Donated medicines to Sri Lanka
    June 7, 2022
  • 0
    Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division
    February 14, 2022

BIO-LABS SISTER CONCERNS

  • Bio-Next Pharmaceuticals
  • Bio-Labs Consumer Health
  • ZHTherapeutics
Copyrights © 2022 Bio-Labs | All rights reserved.